Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
59.32
-1.76 (-2.88%)
Nov 17, 2026, 4:00 PM EST

SHA:688192 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,213291.42250.1674.2121.67364.24
Trading Asset Securities
1,3741,645589.836741,2951,711
Cash & Short-Term Investments
5,5871,936839.99748.21,4162,075
Cash Growth
190.03%130.51%12.27%-47.18%-31.74%246.26%
Accounts Receivable
133.4143.4427.4948.04-7.55
Other Receivables
35.84-----
Receivables
169.24143.4427.4948.04-7.55
Inventory
57.4336.9544.1123.475.07-
Other Current Assets
65.8866.0387.3790.6551.6429.57
Total Current Assets
5,8802,183998.97910.361,4732,112
Property, Plant & Equipment
354.37381.23243.91102.26103.66104.48
Other Intangible Assets
371.63396.43429.85461.98492.02474.9
Long-Term Deferred Charges
2.934.098.6216.997.994.54
Other Long-Term Assets
42.2238.0937.384.795.0649.51
Total Assets
6,6513,0031,7191,4962,0822,746

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
216.2134.8220.3918.578.811.65
Accrued Expenses
66.06331.8245.07182.18208.53182.75
Short-Term Debt
48.91217.45373.83200.11--
Current Portion of Long-Term Debt
465.9291.9741.270.1--
Current Portion of Leases
-21.223.5322.9521.3416.84
Current Income Taxes Payable
17.361.34-0.050-
Current Unearned Revenue
10.515.52.930.98--
Other Current Liabilities
58.1181.1478.0623.499.8210.76
Total Current Liabilities
883.06985.23785.08448.44248.49211.99
Long-Term Debt
770.11688.15683.76138.31--
Long-Term Leases
5.5821.9834.9948.8963.9370.92
Long-Term Unearned Revenue
10.4111.4814.8412.1111-
Total Liabilities
1,6691,7071,519647.75323.43282.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
465.17461.19417.65408.15407.16404.18
Additional Paid-In Capital
5,0044,9563,1362,9542,7572,729
Retained Earnings
-484.8-4,124-3,360-2,514-1,406-669.85
Total Common Equity
4,9841,294193.76848.631,7582,463
Minority Interest
-2.651.836.3---
Shareholders' Equity
4,9811,296200.06848.631,7582,463
Total Liabilities & Equity
6,6513,0031,7191,4962,0822,746

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,2911,2411,157410.3785.2787.76
Net Cash (Debt)
4,296695.51-317.39337.831,3311,987
Net Cash Growth
397.18%---74.62%-33.02%231.62%
Net Cash Per Share
9.221.56-0.770.833.295.52
Filing Date Shares Outstanding
465.17461.19417.65408.15407.16404.18
Total Common Shares Outstanding
465.17461.19417.65408.15407.16404.18
Working Capital
4,9961,197213.89461.931,2251,900
Book Value Per Share
10.712.810.462.084.326.09
Tangible Book Value
4,613897.43-236.09386.651,2661,988
Tangible Book Value Per Share
9.921.95-0.570.953.114.92
Buildings
-227.2----
Machinery
-160.6755.4349.1431.9926.91
Construction In Progress
--169.7213.358.855.04